Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor

NCT06540937 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

DRUG: Leflunomide Pill

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences